EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Case of Lichenoid Drug Eruption Following Risankizumab Therapy

Zachary Levy, Sarah Romanelli Romanelli, Gretchen D. Ball, Stephen A. Switlyk, Alice B. Gottlieb

SKIN The Journal of Cutaneous Medicine · 10.03.2026 · 10 (2) · 3043-3047

DOI: 10.25251/vx1w1107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.03.2026. Verfasst von Zachary Levy und 4 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis (PsO) is a chronic inflammatory disorder that significantly impairs quality of life and is associated with numerous comorbidities. Risankizumab, a biologic therapy targeting the p19 subunit of interleukin (IL)-23, has emerged as a potent treatment option due to its ability to disrupt the IL-23/IL-17 inflammatory cascade responsible for psoriatic pathogenesis. Despite its demonstrated efficacy and safety, risankizumab’s potential for rare adverse reactions necessitates vigilant post-marketing surveillance. This case reports the first documented instance of a lichenoid drug eruption in a 79-year-old female with psoriasis following treatment with risankizumab. The reaction manifested as erythematous patches across her chest, face, neck, and calf, which improved upon cessation of risankizumab and resumption of methotrexate supplemented by narrow-band UVB therapy. This case highlights the need for ongoing surveillance of adverse side effects associated with newer biologic therapies to enhance patient management and safety.

Zitieren

APA

Levy, Z., Romanelli, S. R., Ball, G. D., Switlyk, S. A., & Gottlieb, A. B. (2026). A Case of Lichenoid Drug Eruption Following Risankizumab Therapy. SKIN The Journal of Cutaneous Medicine, 10(2), 3043-3047. https://doi.org/10.25251/vx1w1107

Vancouver

Levy Z, Romanelli SR, Ball GD, Switlyk SA, Gottlieb AB. A Case of Lichenoid Drug Eruption Following Risankizumab Therapy. SKIN The Journal of Cutaneous Medicine. 2026;10(2):3043-3047. doi:10.25251/vx1w1107

BibTeX
@article{Levy2026,
  author = {Levy, Zachary and Romanelli, Sarah Romanelli and Ball, Gretchen D. and Switlyk, Stephen A. and Gottlieb, Alice B.},
  title = {A Case of Lichenoid Drug Eruption Following Risankizumab Therapy},
  journal = {SKIN The Journal of Cutaneous Medicine},
  year = {2026},
  volume = {10},
  number = {2},
  pages = {3043--3047},
  doi = {10.25251/vx1w1107}
}
Kostenlos starten →